In this issue of Surgical Pathology Clinics, guest editor Dr. Alain Borczuk brings his considerable expertise to the topic of New Frontiers in Thoracic Pathology. Top experts provide new insights into emerging technology that will affect thoracic pathology in both neoplastic and non-neoplastic disease. This issue covers updates in the utilization of molecular testing in surgical pathology of lung cancer and mesothelioma, highlights uncommon tumors in the differential of common tumors, and shares new approaches to non-neoplastic disease, including new clinicopathologic entities.
Smoking-Related Interstitial Lung Disease: Historical Perspective and Advances in the Twenty-first Century Granulomatous Lung Diseases: A Practical Approach and Review of Common Entities Update on Silicosis Pathology of COVID-19 Lung Disease Interstitial Lung Abnormalities Evolving Diagnostic Approach of Pulmonary Salivary Gland-type Tumors Sarcoma of the Lung and Mediastinum Nonmesothelial Spindle Cell Tumors of Pleura and Pericardium Invasion and Grading of Pulmonary Non-Mucinous Adenocarcinoma Pathologic Response Evaluation in Neoadjuvant-Treated Lung Cancer Microsatellite Instability, Mismatch Repair, and Tumor Mutation Burden in Lung Cancer Molecular Testing in Lung Cancer: Recommendations and Update Applications of Artificial Intelligence in Lung Pathology
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.